News Release

• June 20, 2024

  Additional Investment in Revital Healthcare (EPZ) Limited
• December 19, 2023

  Announcement of Recapitalization of Africa Healthcare Network (AHN)-Expansion of healthcare infrastructure through the development of dialysis services in sub-Saharan countries
• September 27, 2021

  Glucarpidase (Genetical Recombination) “Megludase® ”Marketing Authorization Approval
• June 23, 2021

  Recombinant Chimeric Monoclonal Antibody "Unituxin®" Marketing Authorization Approval
• March 29, 2021

  Glucarpidase (Genetical Recombination)"OP-07" Application Filed for Marketing Authorization for Methotrexate Intoxication
• February 25, 2021

  Ohara Pharmaceutical is introduced in Newsweek International Edition
• September 24, 2020

  Recombinant Chimeric Monoclonal Antibody "Dinutuximab (OP-08)":Application Filed for Marketing Authorization for Neuroblastoma
• August 17, 2020

  Recombinant Chimeric Monoclonal Antibody “Dinutuximab (OP-08)” Receives Orphan Drug Designation for Neuroblastoma from MHLW
• August 17, 2020

  Glucarpidase (Genetical Recombination) “OP-07” Receives Orphan Drug Designation from MHLW
• April 1, 2020

  Initiation of a Phase I/II Clinical Study of “OP-10” in Japan